This increased fibrotic burden observed histologically was in line with increased gene expression of Col1a1, Col2a1, and Fn and elevated Six1 levels in BLM-treated AT2-SIX1OE mice compared with BLM-treated SPC-rtTA mice (Figure 8, H–J). The gene discussed is COL1A1; the disease is Bloom syndrome.